Sponsor Pipeline

Donghua Zhang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
2
Recruiting
4
Disease Areas
Active Trials by Phase
Not specified
6
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07237230 Clinical Study to Evaluate the Safety and Efficacy of γδ T Cells for the Prevention of… High-Risk Acute Myeloid Leukemia Recruiting
NCT07345728 Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for… Relapsed/Refractory B-cell Malignancies Recruiting
NCT07342244 Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell… AML Not Yet Recruiting
NCT07345741 Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of… R/R B-NHL Not Yet Recruiting
NCT07345780 Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR)… CD7-Positive Hematological Malignancies Not Yet Recruiting
NCT07376720 A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With… Multiple Myeloma Not Yet Recruiting
Disease Areas
Get alerts when Donghua Zhang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free